RAMP1 Proteine (RAMP1)

Rhesus Monkey Receptor (G Protein-Coupled) Activity Modifying Protein 1 (RAMP1) Interaktionspartner

1. Study provides accurate validation of functional CGRP receptor expression throughout the brainstem and the spinal cord of non-human primates: several areas in the brainstem were shown to express CLR and RAMP1 mRNA and protein

Human Receptor (G Protein-Coupled) Activity Modifying Protein 1 (RAMP1) Interaktionspartner

1. T-A-T RAMP1 gene haplotype might have utility as a genetic marker for Essential Hypertension and that the RAMP1 gene may be associated with increased susceptibility to Essential Hypertension in a Japanese population.

2. Data suggest CGRP receptor (CGRPR) ECL2 (extracellular loop 2 domain) enables interaction with N-terminal residues of CGRP; this provides evidence for dual involvement of ECL2 in two-domain binding model of CGRP/CGRPR interaction; CGRPR is obligate heterodimer of CLR/RAMP1. (CGRP = calcitonin gene-related peptide; CLR = calcitonin receptor-like receptor; RAMP1 = receptor [calcitonin] activity modifying protein 1)

3. Evidence that DNA methylation at RAMP1 gene promoter plays a role in migraine was described.

4. RAMP1 rs7590387 has a role in the transformation of episodic migraine into medication overuse headache.

5. Data suggest that ligand binding of a G protein-coupled receptor (GPCR) may inform drug development targeting calcitonin receptor-like receptor (CLR):receptor activity-modifying proteins RAMP1/2 complexes.

6. A novel functional role for RAMP1 in regulation of CaSR signalling in addition to its known role in receptor trafficking, is reported.

7. multiple NKX3.1 binding sites were found in the RAMP1 locus in human prostate cancer cells and in the normal mouse prostate.

8. RAMP1 overexpression enhances the promoting effect that exogenous CGRP has on osteogenic differentiation

9. No significant association of the tested SNPs of the RAMP1 gene were found with migraine susceptibility.

10. CLR and RAMP1 co-localize in the enteric nervous system of human stomach, ileum, and colon, and are in close proximity to their ligands CGRP and IMD

11. The present finding demonstrated that RAMP1 immunoreactivity was localized in many neurons and phenopalatine ganglion.

12. lower expression in bronchial biopsies from subjects with asthma

13. The T-A-C haplotype is a genetic marker for cerebral infarction, and RAMP1 is associated with increased susceptibility to cerebral infarction.

14. These data for the first time pinpoint a specific RAMP1 residue important for both antagonist and agonist potency and are consistent with the N-terminal domain of RAMP1 forming the binding pocket interface with calcitonin receptor-like receptor.

15. RAMP1 overexpression attenuates Ang-II-induced hypertension and induces a protective change in cardiovascular autonomic regulation

16. Receptor activity modifying proteins interaction with human and porcine calcitonin receptor-like receptor (CRLR) in HEK-293 cells

17. Co-expression of RAMP1 and CRLR reconstituted a CGRP receptor that was able to activate the pheromone-signaling pathway with pharmacological properties similar to those observed previously in mammalian cells.

18. Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists.

19. The CGRP receptor components, RAMP1 and CRLR, are down-regulated during myeloid differentiation of CD34+ cells, and CGRP receptor selectively promotes the development of CFU-GM.

20. results show the presence of calcitonin receptor-like receptor and receptor activity-modifying proteins in middle meningeal, middle cerebral, pial, and superficial temporal vessels